CLINICAL_TRIALS
trial_result
· 2012-08-23
Clinical Trial Update: A Study of a Melatonin Receptor Agonist to Prevent Migraine [Phase 2]
Summary
Phase 2 study evaluating a melatonin receptor agonist for preventing migraines; the trial was terminated and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Swedish Medical Center | Conditions: Migraine, Migraine With Aura | Phase 2 | Status: TERMINATED | Results posted: 2012-08-23